|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 and hyperosmolarity
1 Department of Medicine, Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia
2 Department of Medicine, Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia; Department of Physiology, University of Sydney, Sydney, NSW, Australia
3 Department of Immunology, Royal North Shore Hospital, Sydney, NSW, Australia
* To whom correspondence should be addressed. E-mail: carpol{at}med.usyd.edu.au.
Methods. Human endothelial cells were exposed to 5mM glucose (control), 25mM (high) glucose or osmotic control for 72 hours. TGF
1 production, cell growth, death and cell cycle progression and the effects of TGF
1 and TGF
neutralisation on these parameters were studied.
Results. High glucose and hyperosmolarity increased endothelial TGF
1 secretion (P<0.0001) and bioactivity (P<0.0001). However high glucose had a greater effect on reducing endothelial cell number (P<0.001) and increasing cellular protein content (P < 0.001) than the osmotic control. TGF
antibody only reversed high glucose's antiproliferative and hypertrophic effects. High glucose altered cell cycle progression and cyclin dependent kinase inhibitor (cdki) expression independent of hyperosmolarity. High glucose increased endothelial cell apoptosis (P < 0.01) while hyperosmolarity induced endothelial cell necrosis (P < 0.001). TGF
antibody did not reverse the apoptotic effects observed with high glucose. Exogenous TGF
1 mimicked the increased S phase delay but not endoreduplication observed with high glucose.
Conclusion. High glucose altered endothelial cell growth, apoptosis and cell cycle progression. These growth effects occurred principally via a TGF
1 autocrine pathway. In contrast, apoptosis and endoreduplication occurred independent of this cytokine and hyperosmolarity.
This article has been cited by other articles:
![]() |
S. Varma, B. K. Lal, R. Zheng, J. W. Breslin, S. Saito, P. J. Pappas, R. W. Hobson II, and W. N. Duran Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1744 - H1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. McGinn, S. Saad, P. Poronnik, and C. A. Pollock High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E708 - E717. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |